Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Retatrutide, also known as LY3437943, is an investigational single-molecule triple agonist studied for activity at the GIP, GLP-1, and glucagon receptors
Efficacy and Safety of Semaglutide 7.2mg in ObesitySTEP UP Trial
Nordic registry studies comparing cancer incidence in patients prescribed GLP-1 receptor agonists versus other diabetes medications have generally found no elevated risk after adjustment for available confounding factors
The response rate proved equally impressive: 91.7% of participants at the 12mg dose achieved at least 10% weight loss, and the majority achieved 15% or greater
Preclinical studies demonstrated that GLP-1 receptor agonists increased bone formation and reduced bone resorption in metabolic bone disease models, including diabetic osteoporosis, postmenopausal osteoporosis, and glucocorticoid-induced osteoporosis
US$ 29.67
US$ 23.74
US$ 23.72
US$ 27.57
US$ 29.53
US$ 29.44
US$ 23.34
